Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug approvals
drug approvals
Study: FDA approves new oncology drugs quicker than EMA
RAPS.org
Mon, 06/13/22 - 10:33 am
JAMA
regulatory
drug approvals
FDA
EMA
Europe
FDA Approvals Roundup: Camzyos, Vivjoa, Epsolay
RAPS.org
Thu, 05/5/22 - 10:23 am
FDA
drug approvals
Bristol Myers Squibb
Camzyos
Mycovia
Vivjoa
Sol-Gel
Epsolay
FDA's use of adcomms prior to drug approval decreased over the last decade
RAPS.org
Tue, 05/3/22 - 10:49 pm
FDA
regulatory
advisory panels
drug approvals
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Will the COVID-19 Vaccine Speed Up Biotech Production?
Motley Fool
Wed, 02/23/22 - 10:04 pm
vaccines
COVID-19
drug approvals
drug development
China-Developed Drugs for U.S. Market Could Face Steep Hill
BioSpace
Wed, 02/9/22 - 11:01 am
China
drug approvals
FDA
clinical trials
Cancer therapies lead way as FDA tallies 60 drug approvals in 2021
MedCity News
Sun, 01/2/22 - 11:31 pm
FDA
drug approvals
cancer
oncology
Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 08/4/21 - 10:44 pm
Biogen
Aduhelm
FDA
drug approvals
Alzheimer's disease
'Erratic' FDA and inconsistent drug decisions put doctors off new meds: survey
Fierce Pharma
Tue, 08/3/21 - 11:49 pm
FDA
trust
physicians
drug approvals
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Novartis
AbbVie
GSK
Roche
Eli Lilly
AstraZeneca
FDA
drug launches
drug approvals
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
FDA staffers defend Aduhelm approval in JAMA editorial
Pharmaforum
Wed, 07/14/21 - 10:18 am
FDA
Biogen
Aduhelm
JAMA
drug approvals
Alzheimer's disease
Novartis leads and Bristol lags on novel drug approvals
EP Vantage
Wed, 07/14/21 - 10:10 am
Novartis
Bristol Myers Squibb
drug approvals
FDA
House committees kick off investigation into how Biogen's Aduhelm won approval
Endpoints
Tue, 07/13/21 - 10:48 am
US Congress
Biogen
Aduhelm
FDA
drug approvals
Alzheimer's disease
Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug
Stat
Wed, 06/30/21 - 10:20 pm
FDA
Biogen
Aduhelm
drug approvals
Patient experience data in regulatory decisions: Questions abound in first FDA report
Endpoints
Wed, 06/30/21 - 11:13 am
FDA
regulatory
patients
patient experience data
drug approvals
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
FDA
drug approvals
Argenx
Novartis
AstraZeneca
Astellas
UCB Pharma
Ascendis Pharma
ChemoCentryx
Axsome Therapeutics
US appetite for Covid-19 treatments remains undiminished
EP Vantage
Thu, 05/27/21 - 10:49 am
FDA
COVID-19
drug approvals
When FDA Makes You An Offer You Can’t Refuse
FDA Law Blog
Wed, 05/26/21 - 12:02 am
FDA
regulatory
drug approvals
CDER
DRG
How pandemic challenges delayed FDA approvals
BioCentury
Thu, 05/6/21 - 10:31 am
FDA
drug approvals
pandemic
COVID-19
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »